Kiyotaka Ando

发表

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study

R. Nishimura, K. Utsunomiya, Hiroshi Takahashi, 2017, Expert opinion on pharmacotherapy.

Comparison of glycemic variability in patients with type 2 diabetes given sitagliptin or voglibose: a continuous glucose monitoring-based pilot study.

R. Nishimura, K. Utsunomiya, Kiyotaka Ando, 2013, Diabetes technology & therapeutics.

Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study

R. Nishimura, K. Utsunomiya, Kiyotaka Ando, 2014, Expert opinion on pharmacotherapy.

Associations of Homocysteine with B Vitamins and Zinc in Serum Levels of Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Kiyotaka Ando, Keiji Fujimoto, H. Yoshida, 2021, Journal of nutritional science and vitaminology.

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring

R. Nishimura, K. Utsunomiya, Y. Onda, 2017, Journal of diabetes investigation.

24-Hour Glycemic Variations in Drug-Naïve Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study

R. Nishimura, K. Utsunomiya, Kiyotaka Ando, 2013, PloS one.

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

Masaya Sakamoto, Kiyotaka Ando, R. Nishimura, 2012, Cardiovascular Diabetology.

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes

R. Nishimura, K. Utsunomiya, Y. Onda, 2016, Diabetology & Metabolic Syndrome.

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?

R. Nishimura, K. Utsunomiya, Kiyotaka Ando, 2015, PloS one.

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study

Kiyotaka Ando, R. Nishimura, K. Utsunomiya, 2017, PloS one.

Population‐based cross‐sectional study on insulin resistance and insulin‐secretory capacity in Japanese school children

N. Tajima, R. Nishimura, K. Utsunomiya, 2017, Journal of diabetes investigation.

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study.

R. Nishimura, K. Utsunomiya, Hiroshi Takahashi, 2016, Diabetes research and clinical practice.

Association of Renal Function and Statin Therapy with Lipoprotein(a) in Patients with Type 2 Diabetes

Kiyotaka Ando, Ryo Sato, Chika Hiraishi, 2023, Journal of atherosclerosis and thrombosis.